Lijun Zhu Selected Research

ATP-Binding Cassette Sub-Family B Member 4

1/2020	Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Mediate the Disposition of Leonurine-10-O-β-glucuronide.
1/2019	Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
7/2017	Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides.
1/2016	In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijun Zhu Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 01/2004
12	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2015
8	Stroke (Strokes) 01/2022 - 01/2013
8	Obesity 01/2019 - 01/2011
7	Hypertension (High Blood Pressure) 10/2021 - 09/2017
6	Carcinogenesis 01/2019 - 04/2012
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2021
5	Rheumatoid Arthritis 01/2022 - 01/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 04/2015
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017 - 01/2017
3	Infections 12/2022 - 03/2016
3	Ischemia 07/2022 - 02/2002
3	Ischemic Stroke 02/2022 - 02/2013
3	Pain (Aches) 01/2022 - 10/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2015
3	Atherosclerosis 01/2020 - 10/2019
3	Genetic Predisposition to Disease (Genetic Predisposition) 11/2019 - 11/2017
3	Carcinoma (Carcinomatosis) 04/2016 - 03/2006
3	Multiple Myeloma 01/2009 - 01/2005
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2022 - 08/2015
2	Osteoarthritis 01/2022 - 01/2017
2	Critical Illness (Critically Ill) 09/2021 - 01/2020
2	Cardiotoxicity 12/2020 - 05/2011
2	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2016
2	Atherosclerotic Plaque (Atheroma) 11/2019 - 10/2019
2	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2019 - 01/2018
2	Neural Tube Defects (Exencephaly) 11/2019 - 12/2018
2	Vitamin D Deficiency 10/2018 - 01/2018
2	Arthritis (Polyarthritis) 04/2018 - 01/2017
2	Anxiety Disorders (Anxiety Disorder) 01/2018 - 01/2017
2	Exanthema (Rash) 01/2017 - 10/2015
2	Squamous Cell Carcinoma of Head and Neck 01/2017 - 02/2016
2	Asthma (Bronchial Asthma) 08/2016 - 01/2015
2	Lymphoma (Lymphomas) 06/2010 - 05/2005
1	Infarction (Infarctions) 07/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2022

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2005
12	Pharmaceutical PreparationsIBA 01/2022 - 01/2004
9	EnzymesIBA 06/2021 - 07/2010
8	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2014
6	Messenger RNA (mRNA)IBA 01/2021 - 01/2005
5	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2019 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
4	ORALIT (ORS)IBA 10/2021 - 09/2017
4	Therapeutic UsesIBA 01/2021 - 01/2009
4	Polysaccharides (Glycans)IBA 01/2020 - 01/2017
4	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2020 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2014
4	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 06/2010 - 01/2005
3	Peptides (Polypeptides)IBA 01/2022 - 12/2006
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 12/2020
3	PolymersIBA 11/2021 - 06/2021
3	Uric Acid (Urate)IBA 01/2021 - 02/2013
3	CholesterolIBA 01/2021 - 12/2018
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2019 - 06/2013
3	Multidrug Resistance-Associated Protein 2IBA 01/2019 - 04/2015
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2018 - 04/2015
3	GlucuronidesIBA 12/2018 - 01/2016
3	hydroxide ionIBA 01/2018 - 01/2017
3	Bortezomib (Velcade)FDA Link 06/2010 - 03/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 02/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2021
2	Simvastatin (Zocor)FDA LinkGeneric 01/2022 - 01/2021
2	AlkaloidsIBA 01/2022 - 01/2014
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 08/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2018
2	Insulin-Like PeptidesIBA 01/2020 - 09/2017
2	dimethylethylsilylimidazoleIBA 01/2020 - 07/2018
2	LipidsIBA 01/2020 - 10/2019
2	Apolipoproteins E (ApoE)IBA 11/2019 - 10/2019
2	CytokinesIBA 01/2019 - 04/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2017
2	Vitamin D FDA LinkGeneric 10/2018 - 01/2018
2	factor V LeidenIBA 01/2018 - 12/2017
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 01/2018
2	3' Untranslated Regions (3' UTR)IBA 08/2017 - 01/2017
2	acacetinIBA 07/2017 - 06/2017
2	Methylnitronitrosoguanidine (MNNG)IBA 04/2016 - 04/2012
2	GlucocorticoidsIBA 01/2011 - 07/2010
2	Gemcitabine FDA Link 11/2009 - 03/2006
2	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 11/2009 - 03/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2005 - 01/2005
1	InflammasomesIBA 12/2022
1	salicylhydroxamic acid (SHAM)IBA 07/2022
1	ChloridesIBA 07/2022
1	ZincIBA 02/2022
1	Rab geranylgeranyl transferase beta-subunitIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Lipoprotein(a)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	geranylgeraniolIBA 01/2022

Therapy/Procedure

7	Therapeutics 01/2022 - 11/2009
4	Drug Therapy (Chemotherapy) 01/2022 - 03/2006
3	Photothermal Therapy 11/2021 - 01/2021
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2015 - 01/2014
2	Transplantation 01/2022 - 06/2012
2	Precision Medicine 01/2022 - 01/2021
1	Stents 01/2022